A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia

Schizophrenia Research

Volumn 113, Issue 1, 2009, Pages 84-94

  Yoshida, Takeshi ^a,b,c   McCarley, Robert W ^a   Nakamura, Motoaki ^a,c   Lee, KangUk ^a,c   Koo, Min Seong ^a,c   Bouix, Sylvain ^a,c   Salisbury, Dean F ^a,d   Morra, Lindsay ^a   Shenton, Martha E ^a,c   Niznikiewicz, Margaret A ^a  

^a Laboratory of Neuroscience   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

Amygdala hippocampal complex; Chronic schizophrenia; MRI; Prospective study; Schizophrenia; Superior temporal gyrus

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MALE; NEGATIVE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA; TEMPORAL LOBE; VOLUMETRY;

ADULT; AMYGDALA; BRAIN MAPPING; CHRONIC DISEASE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; STATISTICS AS TOPIC; TEMPORAL LOBE;

EID: 67650032529     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.05.004     Document Type: Article

References (68)

1. Alho K. Cerebral generators of mismatch negativity (MMN) and its magnetic counterpart (MMNm) elicited by sound changes. Ear Hear. 16 1 (1995) 38-51
2. Anderson J.E., Wible C.G., McCarley R.W., Jakab M., Kasai K., and Shenton M.E. An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia. Schizophr. Res. 58 2-3 (2002) 123-134
3. Barta P.E., Pearlson G.D., Powers R.E., Richards S.S., and Tune L.E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am. J. Psychiatry 147 11 (1990) 1457-1462
4. Bartha R., Williamson P.C., Drost D.J., Malla A., Carr T.J., Cortese L., Canaran G., Rylett R.J., and Neufeld R.W. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 54 10 (1997) 959-965
5. Blakemore S.J., and Frith C.D. Functional neuroimaging studies of schizophrenia. In: Toga AW F.R., Mazziotta, and J.C. (Eds). Brain Mapping: the Disorders (2000), Academic Press, San Diego 523-544
6. Cahn W., Hulshoff Pol H.E., Lems E.B., van Haren N.E., Schnack H.G., van der Linden J.A., Schothorst P.F., van Engeland H., and Kahn R.S. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch. Gen. Psychiatry 59 11 (2002) 1002-1010
7. Copolov D.L., Seal M.L., Maruff P., Ulusoy R., Wong M.T., Tochon-Danguy H.J., and Egan G.F. Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res. 122 3 (2003) 139-152
8. Davis K.L., Buchsbaum M.S., Shihabuddin L., Spiegel-Cohen J., Metzger M., Frecska E., Keefe R.S., and Powchik P. Ventricular enlargement in poor-outcome schizophrenia. Biol. Psychiatry. 43 11 (1998) 783-793
9. DeLisi L.E. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr. Bull. 34 2 (2008) 312-321
10. DeLisi L.E., and Hoff A.L. Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophrenia. Psychiatry Res. 138 3 (2005) 265-268
11. DeLisi L.E., Tew W., Xie S., Hoff A.L., Sakuma M., Kushner M., Lee G., Shedlack K., Smith A.M., and Grimson R. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol. Psychiatry 38 6 (1995) 349-360
12. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., and Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 74 3 (1997) 129-140
13. DeLisi L.E., Sakuma M., Maurizio A.M., Relja M., and Hoff A.L. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res. 130 1 (2004) 57-70
14. Dorph-Petersen K.A., Pierri J.N., Perel J.M., Sun Z., Sampson A.R., and Lewis D.A. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30 9 (2005) 1649-1661
15. Gerig G.K.O., Kikinis R., and Jolesz F.A. Nonlinear anisotropic filtering of MRI data. IEEE. Trans. Med. Imag. 11 (1992) 221-232
16. Gogtay N., Sporn A., Clasen L.S., Nugent III T.F., Greenstein D., Nicolson R., Giedd J.N., Lenane M., Gochman P., Evans A., and Rapoport J.L. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Arch. Gen. Psychiatry 61 1 (2004) 17-22
17. Gur R.E., Cowell P., Turetsky B.I., Gallacher F., Cannon T., Bilker W., and Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry 55 2 (1998) 145-152
18. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindstrom L.H., and Iyo M. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC. Psychiatry 5 1 (2005) 6
19. Hirayasu Y., Shenton M.E., Salisbury D.F., Dickey C.C., Fischer I.A., Mazzoni P., Kisler T., Arakaki H., Kwon J.S., Anderson J.E., Yurgelun-Todd D., Tohen M., and McCarley R.W. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am. J. Psychiatry 155 10 (1998) 1384-1391
20. Hoffman R.E., Hawkins K.A., Gueorguieva R., Boutros N.N., Rachid F., Carroll K., and Krystal J.H. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch. Gen. Psychiatry 60 1 (2003) 49-56
21. Honea R., Crow T.J., Passingham D., and Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 162 12 (2005) 2233-2245
22. Hulshoff Pol H.E., and Kahn R.S. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 34 2 (2008) 354-366
23. Illowsky B.P., Juliano D.M., Bigelow L.B., and Weinberger D.R. Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J. Neurol. Neurosurg. Psychiatry. 51 2 (1988) 209-213
24. Javitt D.C., Steinschneider M., Schroeder C.E., and Arezzo J.C. Role of cortical N-methyl-d-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 93 21 (1996) 11962-11967
25. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Lee C.U., Ciszewski A.A., Yurgelun-Todd D., Kikinis R., Jolesz F.A., and McCarley R.W. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am. J. Psychiatry 160 1 (2003) 156-164
26. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Spencer M.H., Yurgelun-Todd D.A., Kikinis R., Jolesz F.A., and McCarley R.W. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 60 8 (2003) 766-775
27. Kemali D., Maj M., Galderisi S., Milici N., and Salvati A. Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study. Biol. Psychiatry. 26 7 (1989) 756-759
28. Konradi C., and Heckers S. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol. Psychiatry 50 10 (2001) 729-742
29. Kreitschmann-Andermahr I., Rosburg T., Demme U., Gaser E., Nowak H., and Sauer H. Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Brain. Res. Cogn. Brain Res. 12 1 (2001) 109-116
30. Lewis D.A., and Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 12 9 (2006) 1016-1022
31. Lieberman J., Chakos M., Wu H., Alvir J., Hoffman E., Robinson D., and Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biol. Psychiatry 49 6 (2001) 487-499
32. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., Keefe R.S., Green A.I., Gur R.E., McEvoy J., Perkins D., Hamer R.M., Gu H., and Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 62 4 (2005) 361-370
33. Light G.A., and Braff D.L. Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. Am. J. Psychiatry 162 9 (2005) 1741-1743
34. Mathalon D.H., Sullivan E.V., Lim K.O., and Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 58 2 (2001) 148-157
35. Morris J.S., Frith C.D., Perrett D.I., Rowland D., Young A.W., Calder A.J., and Dolan R.J. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 383 6603 (1996) 812-815
36. Naatanen N. Attentional and Brain Function (1992), Lawrence Erlbaum Associates, Hillsdale, NJ
37. Nasrallah H.A., Olson S.C., McCalley-Whitters M., Chapman S., and Jacoby C.G. Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Arch. Gen. Psychiatry. 43 2 (1986) 157-159
38. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., Koo M.S., Shenton M.E., and McCarley R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry 62 7 (2007) 773-783
39. Nair T.R., Christensen J.D., Kingsbury S.J., Kumar N.G., Terry W.M., and Garver D.L. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res. 74 3 (1997) 141-150
40. Ohrmann P., Siegmund A., Suslow T., Spitzberg K., Kersting A., Arolt V., Heindel W., and Pfleiderer B. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr. Res. 73 2-3 (2005) 153-157
41. Ohrmann P., Siegmund A., Suslow T., Pedersen A., Spitzberg K., Kersting A., Rothermundt M., Arolt V., Heindel W., and Pfleiderer B. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J. Psychiatr. Res. 41 8 (2007) 625-634
42. Olbrich H.M., Valerius G., Rusch N., Buchert M., Thiel T., Hennig J., Ebert D., and Van Elst L.T. Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study. World J. Biol. Psychiatry 9 1 (2008) 59-63
43. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 1 (1971) 97-113
44. Panenka W.J., Khorram B., Barr A.M., Smith G.N., Lang D.J., Kopala L.C., Vandorpe R.A., and Honer W.G. A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia. Schizophr. Res. 94 1-3 (2007) 288-292
45. Rajarethinam R., DeQuardo J.R., Miedler J., Arndt S., Kirbat R., Brunberg J.A., and Tandon R. Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology. Psychiatry Res. 108 2 (2001) 79-87
46. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., Nicolson R., Bedwell J., Lenane M., Zijdenbos A., Paus T., and Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 56 7 (1999) 649-654
47. Ropohl A., Sperling W., Elstner S., Tomandl B., Reulbach U., Kaltenhauser M., Kornhuber J., and Maihofner C. Cortical activity associated with auditory hallucinations. Neuroreport 15 3 (2004) 523-526
48. Sabri M., Kareken D.A., Dzemidzic M., Lowe M.J., and Melara R.D. Neural correlates of auditory sensory memory and automatic change detection. Neuroimage 21 1 (2004) 69-74
49. Saijo T., Abe T., Someya Y., Sassa T., Sudo Y., Suhara T., Shuno T., Asai K., and Okubo Y. Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin. Neurosci. 55 1 (2001) 41-47
50. Salisbury D.F., Kuroki N., Kasai K., Shenton M.E., and McCarley R.W. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch. Gen. Psychiatry 64 5 (2007) 521-529
51. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N. Engl. J. Med. 327 9 (1992) 604-612
52. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 49 1-2 (2001) 1-52
53. Squire L.R., and Zola S.M. Structure and function of declarative and nondeclarative memory systems. Proc. Natl. Acad. Sci. U. S. A. 93 24 (1996) 13515-13522
54. Theberge J., Bartha R., Drost D.J., Menon R.S., Malla A., Takhar J., Neufeld R.W., Rogers J., Pavlosky W., Schaefer B., Densmore M., Al-Semaan Y., and Williamson P.C. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am. J. Psychiatry 159 11 (2002) 1944-1946
55. Theberge J., Al-Semaan Y., Williamson P.C., Menon R.S., Neufeld R.W., Rajakumar N., Schaefer B., Densmore M., and Drost D.J. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am. J. Psychiatry 160 12 (2003) 2231-2233
56. Theberge J., Williamson K.E., Aoyama N., Drost D.J., Manchanda R., Malla A.K., Northcott S., Menon R.S., Neufeld R.W., Rajakumar N., Pavlosky W., Densmore M., Schaefer B., and Williamson P.C. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br. J. Psychiatry 191 (2007) 325-334
57. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., and Javitt D.C. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 57 12 (2000) 1139-1147
58. van de Ven V.G., Formisano E., Roder C.H., Prvulovic D., Bittner R.A., Dietz M.G., Hubl D., Dierks T., Federspiel A., Esposito F., Di Salle F., Jansma B., Goebel R., and Linden D.E. The spatiotemporal pattern of auditory cortical responses during verbal hallucinations. Neuroimage 27 3 (2005) 644-655
59. van Elst L.T., Valerius G., Buchert M., Thiel T., Rusch N., Bubl E., Hennig J., Ebert D., and Olbrich H.M. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol. Psychiatry 58 9 (2005) 724-730
60. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Mandl R.C., Collins D.L., Evans A.C., and Kahn R.S. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology 32 10 (2007) 2057-2066
61. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Brans R., Carati I., Rais M., and Kahn R.S. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry. 63 1 (2008) 106-113
62. Vita A., Sacchetti E., Valvassori G., and Cazzullo C.L. Brain morphology in schizophrenia: a 2- to 5-year CT scan follow-up study. Acta Psychiatr. Scand. 78 5 (1988) 618-621
63. Wells W G.W., Kikinis R., and Jolesz F.A. Adaptive segmentation of MRI data. IEEE. Trans. Med. Imag. 15 (1996) 429-442
64. Whitworth A.B., Kemmler G., Honeder M., Kremser C., Felber S., Hausmann A., Walch T., Wanko C., Weiss E.M., Stuppaeck C.H., and Fleischhacker W.W. Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients. Psychiatry Res. 140 3 (2005) 225-237
65. Wible C.G., Shenton M.E., Hokama H., Kikinis R., Jolesz F.A., Metcalf D., and McCarley R.W. Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study. Arch. Gen. Psychiatry 52 4 (1995) 279-288
66. Woods B.T., Yurgelun-Todd D., Benes F.M., Frankenburg F.R., Pope Jr. H.G., and McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol. Psychiatry. 27 3 (1990) 341-152
67. Wood S.J., Velakoulis D., Smith D.J., Bond D., Stuart G.W., McGorry P.D., Brewer W.J., Bridle N., Eritaia J., Desmond P., Singh B., Copolov D., and Pantelis C. A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr. Res. 52 1-2 (2001) 37-46
68. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 157 1 (2000) 16-25